Imaging Recommendation for 1 cm Enhancing Sternal Lesion
For a 1 cm enhancing sternal lesion, order CT chest with IV contrast to define the extent of bone destruction and soft tissue involvement, followed by MRI of the chest with and without contrast for superior soft tissue characterization and to assess for marrow involvement.
Primary Imaging Approach
The initial workup should prioritize CT with IV contrast as the foundational study. CT excels at demonstrating the precise extent of bone destruction in sternal lesions and simultaneously evaluates for soft tissue infiltration 1. This is critical information for determining whether the lesion is benign versus malignant and for planning potential surgical resection or radiation therapy.
Why CT First?
- Bone detail: CT provides superior visualization of cortical destruction, trabecular changes, and the exact anatomical extent of sternal involvement 1
- Soft tissue assessment: Contrast enhancement helps differentiate between simple bone lesions and those with aggressive soft tissue components 1
- Surgical planning: The combination of bone and soft tissue information is essential if resection is being considered 2
Add MRI for Complete Characterization
MRI chest with and without contrast should follow CT to provide complementary information:
- Superior soft tissue resolution: MRI better characterizes the nature and extent of soft tissue invasion 2
- Marrow involvement: MRI is more sensitive for detecting bone marrow edema and infiltration
- Lesion characterization: Enhancement patterns on MRI can help distinguish benign from malignant processes 3
Evidence from Breast Cancer Metastases
While the provided evidence focuses on sternal lesions detected incidentally on breast MRI, it demonstrates that MRI is more sensitive than bone scan, PET/CT, or chest CT alone for detecting sternal lesions 3. In that study, malignant sternal lesions showed characteristic features including rapid initial enhancement and delayed washout curves 3. This supports MRI's role in characterizing enhancing sternal lesions.
Consider PET/CT for Specific Scenarios
FDG-PET/CT may be appropriate if:
- There is concern for metastatic disease (primary malignancy elsewhere)
- You need to assess for additional sites of disease
- The lesion is >8 mm and metabolic activity would change management
However, PET/CT should not replace anatomic imaging with CT and MRI, as it provides less detailed anatomic information about the sternal lesion itself.
Common Pitfalls to Avoid
- Don't rely on plain radiography: Chest X-rays have poor sensitivity for sternal lesions and provide inadequate detail for characterization 4
- Don't skip contrast: The "enhancing" nature of this lesion on prior imaging suggests vascularity; contrast is essential to characterize enhancement patterns
- Don't order imaging in isolation: The combination of CT (for bone) and MRI (for soft tissue/marrow) provides complementary information that neither alone can offer
Clinical Context Matters
The differential diagnosis for a 1 cm enhancing sternal lesion includes:
- Infection: Primary sternal osteomyelitis (consider if inflammatory markers elevated) 5
- Malignancy: Metastatic disease, lymphoma, or primary bone tumor
- Benign lesions: Langerhans cell histiocytosis, hemangioma, or other benign bone lesions 2
The imaging algorithm should be paired with clinical assessment of risk factors (history of malignancy, recent surgery, immunosuppression, trauma) and laboratory evaluation (inflammatory markers, cultures if infection suspected).